Introduction
Precise genome editing is a powerful genetic tool for the study of gene function and gene therapy. It has traditionally been achieved by introducing mutations into target sites through spontaneous homologous recombination of donor DNA. However, the rate of spontaneous homologous recombination in mammalian cells is too low (10 À6 ) to be of wide use [1] .
The recombination frequency can be increased by inducing double-strand breaks (DSBs) in the target DNA sequence [2] . Zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas9 system are the three main technologies which have been developed to generate sitespecific DSBs [3] [4] [5] [6] . Among these custom designed nuclease systems, the CRISPR/Cas9 system is the most popular genome editing tool due to its simplicity of manipulation and the highest efficiency in introducing a DSB on the target site. The ideal precise gene-editing system requires high efficient homology-directed repair (HDR), cost-efficient detection and isolation of genetically modified cells, and most importantly, no scar left behind after gene editing. A short DNA oligo-based donor system was directly used in precise gene editing [7] . In this application, the oligo donor DNA contains an editing sequence to be used to correct the mutated sequence on the chromosome gene locus. By cotransfection of the donor oligos with CRISPR/Cas9 and sgRNA expression vectors into the cells, the precise gene editing can be achieved by the integration of the donor oligos into the target gene site by HDRbased DNA DSB repairing mechanism [8] . Since there is no selection marker gene on donor oligos, detection and isolation of genetically modified cells is labor intensive. Alternatively, the usage of donor DNA with a selection marker gene can efficiently enrich HDR-based positive clones, therefore higher purity of positive cell collection can be obtained [9, 10] . However, the marker gene remained in the genome may suppress the allele transcription or unintentionally disrupt gene splicing [11] . The Cre/LoxP system has been used for removing marker genes, which is known as marker-free but actually leaves behind a 34-base pair of loxP sequence along with the targeted mutation [12] . This small ectopic sequence has the potential to affect the expression of adjacent genes in mammalian cells [13] . To achieve seamless gene editing, the piggyBac transposon with a selection marker can be removed efficiently without leaving behind any remnant sequence. Still, the reintegration of the transposon into other chromosomal sites catalyzed by the piggyBac transposon occurs in greater than 70% cells [9, 10] .
Single-strand annealing (SSA) is one of homologous recombination-based DNA repair mechanisms. SSA can promote recombination between tandem repeated DNA sequences and induce deletion of the intervening fragment [14, 15] . Although non-homologous end joining (NHEJ) is the predominant mechanism among DSB repair pathways in mammals, SSA could become more likely if substantial repetitive elements are found proximal to the break ends [16] . Previously, we successfully developed a series of SSA repair-mediated surrogate reporters for measuring the activity of artificial site-specific nucleases [15] [16] [17] [18] [19] . When DSBs are introduced into the surrogate reporters, the reporter genes can be repaired precisely through the SSA mechanism. The efficiency and sensitivity of the SSADsRed-Puro R -eGFP reporter with direct repeat lengths more than 200 bp was shown to be much higher than the NHEJ-DsRed-Puro R -eGFP reporter [17] . Based on these observations, we developed a novel CRISPR/Cas9-induced precise gene-editing method by employing the SSA-mediated homologous recombination mechanism into the system (Fig. 1A) . By including a direct repeat containing a substitute sequence used to correct the mutations on target site within leftand right-HDR arms, we designed chromosomal integration cassette with positive and negative selection marker genes (Fig. 1B) . After an integration of the cassette into the target site mediated by CRISPR/ Cas9, we enriched the positive cells with positive selection marker (Puromycin). In the second step, the selection marker genes within the cassette were knocked out by the SSA-mediated DNA DSB repairing mechanism without any scar left behind. We tested this novel method on CCR5 and APP loci and finally demonstrated, respectively, up to 45.83% and 68% of precise genome editing efficiency.
Results
Precise genome editing at CCR5 site using the CCR5.eGFP.Donor
To test our hypothesis, we devised and experimentally evaluated our novel SSA-mediated precise genome editing approach at the human C-C chemokine receptor type 5 (CCR5) gene locus. The CCR5 of human T cells is the major receptor recognized by HIV-1 virus for infecting target cells. The 32-bp deletion within the CCR5 gene coding region results in nonfunctional receptor and makes the cells resistant to HIV-1 infection [10, 20] . To seamlessly delete the 32-bp sequence at CCR5 gene locus in HEK293T cells, we developed a SSA-mediated strategy that could precisely generate the D32/SalI mutation without leaving a scar in the genome. To this purpose, two sgRNA-Cas9 expression vectors (CCR5.sgRNA-Cas9 and eGFP.sgRNA-Cas9) (Fig. 1C) which were used to target the 32-bp sequence at the CCR5 gene locus and the eGFP target site, respectively, and a HDR-based donor vector (CCR5.eGFP.Donor) (Fig. 1D ) was constructed.
The CCR5.eGFP.Donor vector was designed to replace the 32-bp sequence with 6-bp SalI-recognized sequence harbored in right homologous arm ( Fig. 2A) . For the first round targeting with CCR5.sgRNA-Cas9, the TK-Puro R -eGFP marker gene expression cassette flanked by homologous arms in the CCR5.eGFP.Donor vector can be integrated exactly into the HEK293T cell genome by HDR-based DNA double strand repair mechanism, allowing puromycin (Puro) selection and green fluorescence observation, as well as introducing the D32/SalI mutation into CCR5 site ( Fig. 2A(b) ). In order to remove the selection marker cassette by SSA repair mechanism, two direct repeats were designed and located at the both ends of selection cassette. Two additional Cas9 target sites, which are derived from eGFP gene sequence, were inserted inside the two direct repeats to improve the cassette knockout efficiency. For the second round targeting with eGFP.sgRNA-Cas9, the TK-Puro R -eGFP cassette will be removed seamlessly by SSA-mediated repair. Positive clones were enriched according to the ganciclovir (GCV) negative selection, resulting in exactly the CCR5 D32/SalI mutation ( Fig. 2A(c) ).
CCR5.sgRNA-Cas9 and CCR5.eGFP.Donor were cotransfected into HEK293T cells together with the integration donor vector. Puro-resistant clones with green fluorescence (Fig. 2B ) were picked and screened by PCR and sequencing analyses for confirming the donor cassette integration. The PCR analysis using the primer pairs of P1/P2, P3/P4, and P1/P4 to generate the expected size of 1.0 kb, 1.5 kb, and 1.9 kb fragments ( Fig. 2C ; original images were shown in Fig. S1 ), indicating that 100% of the clones were targeted successfully. The PCR product generated with the primer pair, P3/P4 could be digested by the SalI restriction endonuclease, which suggested that the SalI site was successfully introduced into CCR5 gene in all the picked clones. Furthermore, sequencing results confirmed the desired integration (Fig. 2D) . Surprisingly, the sequencing results also demonstrated all the clones had natural 32-bp deletion on the other allele, which is consistent with the recent report that HEK293T cells are heterozygous for CCR5 D32 mutation [21] .
Precise gene editing requires no scar sequence left behind after gene editing. Thus, unwanted selection cassette was excised by the secondary gene targeting through the CRISPR/Cas9-induced SSA repair. The verified HDR-based positive clone (CCR5#2) generated from the first step was transfected with the eGFP.sgRNA-Cas9 vectors to target the three target sites (one in the eGFP gene and two flanking the TKPuro R -eGFP cassette), followed by negative selection with GCV. After selection for 10 days, 48 clones without green fluorescence (Fig. 2E) were picked, expanded, and screened for successful removal of the selection cassette. Only one positive clone successfully replaced by SalI at CCR5 locus. The PCR products (1.9 kb as designed) generated with the primer pair, P1/P4 for Clone#2-3 were digested with SalI enzyme into shorter fragments (955 bp + 940 bp) ( Fig. 2F ; original images were shown in Fig. S1 ), suggesting that the selection cassette was successfully removed from integration site. Furthermore, T-A cloning and sequencing confirmed the desired CCR5 D32/SalI mutation (Fig. 2G ).
Advanced precise genome editing at CCR5 site using the CCR5.SP1.Donor
For the low selection cassette knock-out efficiency, one speculation is that the NHEJ-based DNA DSB repair of eGFP target site in the middle of the selection cassette may lead to the disappeared fluorescent signal, thereby fluorescent would not assist the visual screening of the GCV resistant clones. To prove this hypothesis, the two eGFP target site flanking the selection cassette in the CCR5.eGFP.Donor was replaced by two SP1 target sites ( Fig. 3A ) and the CCR5.SP1.Donor ( Fig. 1E ) was generated. In this experiment, we replaced the eGFP target sequence with a bacterialderived and higher efficient CRISPR sequence SP1 since we extensively optimized this target sequence in our previous experiments [18] . The previously constructed CCR5.sgRNA-Cas9 vector can be used for the first round of targeting. Then, the SP1.sgRNACas9 (Fig. 1C) vector was generated for the second round of targeting to delete the selection cassette.
In the first round of targeting, CCR5.sgRNA-Cas9 and CCR5.SP1.Donor were cotransfected into HEK293T cells. After drug screening, green fluorescent clones with Puro resistance were picked up (Fig. 3B ). The genomes of expanded cell clones were detected by PCR and sequencing analyses in the same way as previously conducted at CCR5 site. Since the CCR5 gene has been extensively amplified in the laboratory, we designed new primers for integrated detection in order to avoid contamination of PCR aerosol products. The PCR analysis using the primer pairs of P5/P6, P7/P8, and P5/P8 to generate the expected size of 1.4 kb, 1.5 kb, and 2.3 kb fragments ( Fig. 3C ; original images were shown in Fig. S2 ), indicating that 50% of the clones were cassette-inserted successfully. The right homologous arm detection fragment generated with the primer pair, P7/P8 could be digested by the SalI restriction endonuclease (1041 bp + 442 bp), which suggested that the SalI site was successfully introduced into CCR5 gene in all the picked clones. Further sequencing results confirmed the desired integration (Fig. 3D) .
The purified HDR-based positive clone (CCR5#25) was transfected with SP1.sgRNA-Cas9 vector to knock out the selection cassette. After subsequent screening, GCV resistant nonfluorescent clones were picked up to expand (Fig. 3E) . The 2.3-kb amplified fragments by primer pair P5/P8 could be cut into 1041 bp and 1264 bp ( Fig. 3F ; original images were shown in Fig. S2 ), indicating that 45.83% clones have been seamlessly edited. The following T-A cloning and sequencing analyses confirmed the desired integration of SalI site in CCR5 locus (Fig. 3G) . After the optimization of the donor vector, we achieved a higher precise genome editing efficiency.
Efficient precise genome editing at APP site using the APP.SP1.Donor
To further prove the general application of our SSAmediated scarless genome editing system, we tested it in precise editing of human amyloid-beta-precursor protein (APP) gene. The accumulation of neurotoxic amyloid-beta protein (Ab) is one of the main inducer of Alzheimer's disease (AD). The pathogenic mutations, APP Swe (KM670/671NL) leads to increasing abnormal cleavage of APP, causing amyloid-beta protein overproduction [22, 23] . To establish an in vitro disease model, we tested our precise genome editing system to create APP Swe (KM670/671NL) genotype. To this purpose, we introduced two amino acid replacements (KM > NL mutation) into the exon 16 of APP site via our SSA-mediated precise genome editing system.
For editing APP gene locus, APP.sgRNA-Cas9 vector (Fig. 1C ) was constructed to induce DSBs at the APP target sequence and a HDR-based donor vector, APP.SP1.Donor (Fig. 1F ) was generated. The SP1.sgRNA-Cas9 vector which has been constructed at CCR5 site editing was used for the second round of targeting again. As for designing APP.SP1.Donor, we intentionally introduced a XbaI site within editing sequence (KM > NL mutation) for simplified detection of success editing in the right homologous arm (Fig. 4A) . After the first round of targeting by APP.sgRNA-Cas9, the APP.SP1.Donor vector with TK-Puro R -eGFP cassette was integrated exactly into the HEK293T cell genome by homologous recombination, allowing Puro selection and green fluorescence observation ( Fig. 4A(b) ). In the second round of targeting by SP1.sgRNA, the TK-Puro R -eGFP cassette flanked by SP1 target sites was knocked out from genome. SSA-mediated DNA DSB repair occurred via the direct repeats located outside SP1 target sites, resulting in the generation of XbaI recognition site (Fig. 4A(c) ).
After the cotransfection of the APP.sgRNA-Cas9 vector with the APP.SP1.Donor vector, Puro-resistant clones with green fluorescence (Fig. 4B ) were picked and screened by PCR and sequencing analyses in the same way as conducted at CCR5 site. The PCR analysis using the primer pairs of P9/P10, P11/P12, and P9/ P12 for picked clones all generated the expected size of 1.3 kb, 2.2 kb, and 2.5 kb fragments, respectively ( Fig. 4C ; original images were shown in Fig. S3 ), indicating that 50% of the clones were targeted successfully but none of biallelic integration among these were detected. The PCR products with primer pair, P11/P12 for all the positive clones could be digested by the XbaI restriction endonuclease, which suggested that the XbaI site was successfully introduced into APP gene in all the positive clones. Furthermore, sequencing results confirmed the correct integration (Fig. 4D) . The HDR-based positive clone (APP#75) from the first step was transfected with the SP1.sgRNA-Cas9 vector to target the two target sites (flanking the TK-Puro R -eGFP cassette), followed by negative selection with GCV. After selection for 10 days, 50 clones without green fluorescence (Fig. 4E) were screened for PCR detection. Thirty-four of the PCR products (1.9 kb as designed) with primers P9 and P8 could be digested into shorter fragments (560 bp + 1370 bp) ( Fig. 4F ; original images were shown in Fig. S3 ), suggesting 68% clones was positive with the seamless deletion of selection cassette. In addition, T-A cloning and sequencing analyses confirmed the desired integration of XbaI site in APP gene locus (Fig. 4G) .
Random integration detection and off-target analysis
During the two-step genome manipulation, unexpected gene interruption may be caused by the random integration of the selection cassette. Therefore, two pairs of primers, TK-puro-F/R and Puro-eGFP-F/R, were designed to detect the random integration effect. The empty electrophoresis lanes as shown in Fig. 5A ,B (Original images were shown in Fig. S4 ) demonstrated no amplification from the precise edited GCV-resistant clones. Random integration was not found in any screened CCR5-and APP-edited cell clones.
As for off-target analysis, the amplicons of the potential off-target sites from the pool of screened CCR5-and APP-edited cell clones were deep sequenced. The low off-target efficiency of CCR5.sgRNA (<1&) and APP.sgRNA (<0.5&) indicated that off-target effect could be minimized through experimental design (Fig. 5C,D) . However, relatively higher off-target frequency (6%) occurred for SP1.sgRNA targeting (Fig. 5E) , which remains to be changed or modified in the further application of the SSA-based donor design.
Discussion
Precise gene editing has expanded significantly in recent years with the development of artificial nucleases for introducing site-directed DSBs, while the efficiency varies greatly between loci and the strategies [24, 25] . To achieve efficient precise gene editing, several two-step 'pop in & out' technologies have been developed, which first use selection cassettes to guarantee efficient selection of positive clones and again utilize special strategies for subsequent deletion of the exogenetic cassettes. However, the marker excision achieved by the Cre/LoxP strategy will leave a scar in the genome, and the piggyBac strategy has the potential risk to reintegrate the transposon into other chromosomal sites. In addition, HDR pathway was also used to remove the selection cassette by using an empty donor to enable the negative selection [23, 26] .
In this study, we presented a novel method for seamless genome editing by the combined usage of CRISPR/Cas9-induced HDR and SSA DNA repair mechanism. In the initial stage for CCR5 gene editing, the eGFP site was chosen to be the secondary targeting site for inducing the SSA-based deletion of the selection cassette. In the first round of gene targeting, the monoallelic integrating efficiency for selected clones was up to 100%, which is consistent with previous similar studies for CCR5 [10] and b-thalassemia [9] correction. The coupled usage of both the Puro R and eGFP marker genes contributed to the selection and visualization of positive clones. Surprisingly, we detected no biallelic integration at first and further sequencing results showed all the clones had the 32-bp deletion on the other allele. This accidental discovery is just confirmed by the later report that HEK293T cells are heterozygous for CCR5 D32 mutation [21] . As the CCR5.sgRNA target site was chosen from the missing sequence, CCR5.sgRNA-Cas9 failed to target the allele with the D32 mutation to mediate the integration. By CRISPR/Cas9-induced HDR, we successfully integrated the selection cassette into the target locus and introduced the CCR5 D32/SalI mutation. However, the selection cassette remained to be removed. To delete the unwanted selection cassette precisely, we utilized the SSA-mediated repair mechanism for the negative selection in light of previous reports [14, 17] . It was disappointing that only 1 out of the 48 GCV positive clones (2.08%) was confirmed to be seamlessly edited as expected at CCR5 site.
In order to improve the efficiency for removing the selection cassette in the second targeting round, the SP1 target site was used to replace the eGFP target. In the first round of gene targeting, selection cassettes were successfully integrated into the targeted site via the HDR-mediated DNA DSB repair with the rate of 50% efficiency. However, it is exciting that the replacement significantly increased the second round targeting efficiency up to 45.83%. This result suggested that correct design of CRISPR-Cas9 target sequence is crucial for high efficient SSA-mediated scarless genome editing. To further validate the improved design, we subsequently tested it in APP gene. APP target site was confirmed to be homozygous by sequencing before the first round of targeting, in order to avoid naturally heterozygous mutation as occurred at CCR5 site. After the first round of targeting for HDR-based site-specific integration, PCR verification demonstrated that all of the 43 (out of 86) screened clones were monoallelic integrations in APP Swe site. We found PAM mutation and indels around the target site of the unintegrated allele, suggesting that both alleles had been targeted by Cas9. However, only one allele was repaired through HDR pathway, while the other was via NHEJ- mediated DNA DSB repair pathway. This result is consistent with Xi's report [26] . It was amazing that 34 out of 50 GCV-resistant clones (68%) were obtained after the second round of targeting. In addition, our data further suggested that the balance of the length of homologous arms and the SSA arms for the two rounds of targeting is also important. During the two-step genome manipulation, unexpected gene interruption may be caused by the random integration of the selection cassette. However, the PCR analysis results demonstrated no obvious random integration in any screened CCR5 and APP edited cell clones, but the amplicon sequencing analysis did find relatively higher off-target effect (6%) for SP1.sgRNA targeting (Fig. 5E) , which remains to be changed or modified in the further application of the SSA-based donor design. First of all, the change of the SP1.sgRNA in the second round of targeting is the simplest solution. There are kinds of methods for solving the off target problem which have been discussed in our previous article [18] . As for the optimization of the sgRNA structure, it is feasible to shorten the length of sgRNA to improve its specificity [27] . With regard to Cas9 protein, mutation of the amino acid sequence of Cas9 protein to reduce genome-wide offtarget effects [28] and the usage of the Cas9 nickase and paired sgRNAs also could be considered [29] .
In conclusion, our SSA-mediated scarless gene precise editing method does not leave any scar within the genome in contrast to the Cre/LoxP strategy [12] and avoids the risk of reintegration of the piggyBac transposon as the CRISPR/Cas9-piggyBac method [9, 10] , therefore providing an important tool for the future seamless genome editing and gene correction.
Materials and methods

Construction of sgRNA-Cas9 vectors and the donor vectors
In brief, the CRISPR/Cas9 vectors were constructed in a single pll3.7 backbone with the sgRNA and humanized Streptococcus thermophilus Cas9 driven by the U6 and CMV promoters, respectively (Fig. 1C) . The target sites used in this study were shown in Table S1 , and the CCR5 gene target site was previously used by Ye et al. [10] .
The Donor vector was produced by inserting the selection cassette (Fig. 1B) into two homologous arms with direct repeat. The Puro R -eGFP was constructed for positive selection and the TK gene was used for negative selection were driven by the PGK and CAG promoters, respectively. The eGFP marker gene was fused with the Puro R gene by T2A, allowing the visualization of green fluorescence for the integration and deletion of the selection cassette. As for CCR5.eGFP.Donor (Fig. 1D ): The 5 0 -homology arm (878 bp) was amplified by primers CCR5-Left arm-F and CCR5.eGFP-Left arm-R using Human embryonic kidney 293T (HEK293T) genomic DNA as the template. The 3 0 -homology arm (1175 bp) was amplified using overlap PCR. In brief, it was amplified using primers CCR5-Right arm-F and CCR5-Right arm-R to obtain a 843-bp fragment for first round of recombination and using primers CCR5.eGFP-SSA-F and CCR5-SSA-R to obtain a 352 bp fragment as the direct repeat for SSA repair. Then, another round of PCR amplification using the primers CCR5.eGFP-SSA-F and CCR5-Right arm-R and the above two PCR products as templates was performed to obtain the 3 0 -homology arm. PCR fragments after enzyme digestion were inserted into backbone to generate the homologous arm vector. Finally, donor vector was obtained after the selection cassette was inserted into the homologous arm vector.
As for CCR5.SP1.Donor (Fig. 1E) , the newly designed CCR5.SP1-Left arm-R(NotI) and CCR5.SP1-SSA-F(XhoI) were used to replace eGFP target site in the donor vector. The 5 0 -homology arm (878 bp) was amplified by primers CCR5-Left arm-F and CCR5.SP1-Left arm-R (NotI) using CCR5.eGFP.Donor as the template. The 3 0 -homology arm (1175 bp) was amplified by primers CCR5.SP1-SSA-F(XhoI) and CCR5-Right arm-R using CCR5.eGFP.Donor as the template. Homologous arm vector and donor vector were constructed follow the same steps as CCR5.eGFP.Donor. Similarly, APP.SP1.Donor (Fig. 1F ) was designed as follows: The 5 0 -homology arm (1088 bp) was amplified by primers APP-Left arm-F and APP-Left arm-R using Human embryonic kidney 293T (HEK293T) genomic DNA as the template. The 3 0 -homology arm (1633 bp) was amplified using overlap PCR. In brief, it was amplified using primers APP-Right arm-F and APP-Right arm-R to obtain an 1111 bp fragment which worked as homologous arm for HDR and using primers APP-SSA-F and APP-SSA-R to obtain a 552-bp fragment which is the direct repeat for SSA repair. Then, another round of PCR amplification using the primers SSA-F and CCR5-R-R and using the above two PCR products as template was performed to obtain the 3 0 -homology arm. Homologous arm vector and donor vector were constructed follow the same steps as CCR5.eGFP.Donor. Primers used to construct the donor plasmids can be found in Table S2 .
Cell culture
The HEK293T cells used in this study were maintained in Dulbecco's modified Eagle medium (DMEM, Gibco) supplemented with 100 UÁmL À1 penicillin, 100 lgÁmL À1 streptomycin, and 10% (v/v) fetal bovine serum (FBS, Hyclone), at 37°C and 5% CO 2 .
Site-directed integration of the selection cassette by CRISPR/Cas9-induced HDR HEK293T cells were cotransfected with sgRNA-Cas9 and Donor plasmid as the molar ratio of 1.2 : 1 using the ExFectTM transfection reagent (Vazyme Biotech Co., Ltd., Nanjing, China) in 24-well plates (Total of 1.2 lg plasmid DNA per transfection) according to the user manual. Twenty-four hours after transfection, cells were transferred into a 100-mm plate, and on the sixth day after transfection, the medium was supplemented with puromycin (InvivoGen, San Diego, CA, USA) at a final concentration of 3 lgÁmL À1 .
After 10 days of Puro treatment, the clones with fluorescence were chosen and seeded in 48-well plates for proliferation. These clones were further cultured within 12-well plates, and half of the cells of each clone were used for genomic DNA preparation and PCR analysis to confirm the integration. The genomic DNAs from the above clones were prepared using the E.Z.N.A.DNA kit (OMEGA Bio-Tek, Guangzhou, China) following the standard procedure and were used as templates for PCR analysis. To identify the integration mediated by HDR, two primer pairs were designed to detect the two homologous arms separately using the 2 9 Taq Master Mix (Novoprotein, Shanghai, China). arm was used to detect biallelic targeting clones. If both alleles were successfully inserted, this primer pair on the genome could fail to amplify the 2000-bp fragment. The purified PCR products were also identified by sequencing after T-A cloning using a pMD TM 19 -T Vector Cloning Kit (TaKaRa, Dalian, China). Primer sequences are shown in Table S2 and PCR detection results are shown in Table S3 .
Seamless deletion of the selection cassette by CRISPR/Cas9-induced SSA Positive clones from the above procedure were subjected to the secondary targeting for removing the selection cassette. Cells were transfected with the sgRNA-Cas9 vector using the ExFectTM transfection reagent (Vazyme Biothch Co., Ltd.) in 24-well plate (total of 0.5 lg plasmid DNA per transfection) according to the user manual. After 10 days of GCV (Sigma, Saint Louis, MO, USA) treatment (at a final concentration of 4 lgÁmL À1 , Sigma), cell colonies without green fluorescence were chosen, and genomic DNA from these clones was extracted as described above.
To confirm the seamless deletion of the selection cassette and the enzyme mutation, forward primers located upstream of the 5 0 homologous arm and reverse primers located downstream of the 3 0 homologous arm were combined to amplify these fragments which contained the point mutation sites using the 2 9 Taq Master Mix (Novoprotein). PCR products were purified using the E.Z.N.A.Gel Extraction Kit (OMEGA Bio-Tek) following the standard procedure. Wild-type genome and mutant genome were distinguished by enzyme digestion of the purified PCR products. The pMD TM 19 -T Vector Cloning Kit (Takara) also was used to determine the point mutation same as above.
Random integration detection and off-target analysis
In order to detect the random integration of the selection cassette during the two-step genome targeting manipulation, two pairs of primers, Tk-Puro-F/R and Puro-eGFP-F/R spanning two different genes were designed for PCR amplifications. TK-puro-F located in the middle of TK ORF and TK-puro-R from the T2A region were designed to amplify the TK-puro fragment. Puro-eGFP-F located at the end of PGK promoter region and Puro-eGFP-R from the bGH polyA region were designed to amplify the Puro-eGFP fragment. Primer sequences were shown in Table S2 . Random integration was detected by PCR analysis with the genomic DNA from the screened CCR5-and APP-edited cell clones.
As for off-target analysis, nine off-target sites for each sgRNA (CCR5.sgRNA, APP.sgRNA and SP1.sgRNA) were predicted based on the online project (http://www.c risprscan.org/). The amplicons of the potential off-target sites from the pool of screened CCR5-and APP-edited cell clones were deep sequenced. Primers designed for PCR amplification of CCR5, APP, and SP1 off-target sites were shown in Table S4 . The EasyTaq DNA polymerase and the Pfu DNA polymerase (Transgen Biotech, Beijing, China) were used to amplify these fragments for amplicon sequencing. Mutations within the 50-bp upstream and downstream of the target site were counted and off-target efficiency was illustrated by the bar chart.
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